1992
DOI: 10.1016/s0889-8553(21)00181-3
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Variceal Rebleeding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1994
1994
2023
2023

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(3 citation statements)
references
References 105 publications
0
3
0
Order By: Relevance
“…[1][2][3][4] Early rebleed rate after endoscopic sclerotherapy (EST) and endoscopic variceal band-ligation (EVL) ranges from 21% to 52% and 20% to 33%, [5][6][7][8] respectively, with recurrence of bleeding episodes in 29%-50% of patients within the first year after EVL. 9 Chronic sclerotherapy has a rebleed rate of 45%-60% 10 and an eventual failure rate of 35%. 11,12 Patients in whom endotherapy has failed require an alternative second line salvage treatment in the form of surgical intervention for urgent and long-term control of variceal bleeding before hepatic functional decompensation occurs.…”
mentioning
confidence: 99%
“…[1][2][3][4] Early rebleed rate after endoscopic sclerotherapy (EST) and endoscopic variceal band-ligation (EVL) ranges from 21% to 52% and 20% to 33%, [5][6][7][8] respectively, with recurrence of bleeding episodes in 29%-50% of patients within the first year after EVL. 9 Chronic sclerotherapy has a rebleed rate of 45%-60% 10 and an eventual failure rate of 35%. 11,12 Patients in whom endotherapy has failed require an alternative second line salvage treatment in the form of surgical intervention for urgent and long-term control of variceal bleeding before hepatic functional decompensation occurs.…”
mentioning
confidence: 99%
“…The mortality rate of such patients can reach 25%-50% within 1 week without treatment and intervention, and the mortality rate within 1 year is as high as 70% 6 , 7 . Endoscopic hemostasis has been the main method for the treatment of first bleeding from esophagogastric vein rupture 8 , but there are still 10%-20% of patients with first successful hemostasis who experience secondary bleeding, and secondary hemostasis failure is more likely to lead to death 9 . The evaluation of the first hemostatic treatment has been widely reported in many domestic and foreign literatures, but the treatment of hemostasis in patients with rebleeding is rarely evaluated.…”
Section: Discussionmentioning
confidence: 99%
“…There is little doubt that the initial acute bleeding episode is more effectively controlled by sclerotherapy than by other means of medical management, such as vasopressin infusion and balloon tamponade [3]. However, when patients are managed with chronic sclerotherapy, 45% to 60% of patients rebleed at some time [10]. Many of these patients are successfully treated with subsequent sclerotherapy sessions, but the eventual failure rate of sclerotherapy is as high as 35% in some series [11,121. Once sclerotherapy has failed and the patient is bleeding acutely, there are limited options other than emergency surgery.…”
Section: Indications For Emergency Surgerymentioning
confidence: 99%